Georgetown University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Georgetown University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3470
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Georgetown University (GU) is an academic and research institute that offers educational services. The university provides undergraduate and graduate degree programs in the fields of law, medical, medical residencies, business administration and public policy degrees, post-doctoral positions, specialized certificates and continuing education programs. It offers educational services in the areas of business and economics and comparative literature, history, international affairs, language and linguistics, liberal and professional studies, sciences, social sciences, mathematics and computer science, and visual and performing arts and film studies, among others. The university offers services through collaborations with academic and research institutions. GU is headquartered in Washington, Washington D.C., the US.

Georgetown University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Georgetown University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Georgetown University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Georgetown University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Georgetown University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Georgetown University, Medical Devices Deals, 2012 to YTD 2018 9
Georgetown University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Georgetown University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Georgetown Lombardi Comprehensive Cancer Center Partners with John Theurer Cancer Center 11
CalAsia Pharma Enters Into Co-Development Agreement With Georgetown University 12
Licensing Agreements 13
Amarantus BioScience Enters into Option for Licensing Agreement with Georgetown University 13
BioMetrx Enters Into Licensing Agreement With Georgetown University Medical Center For Rasstore 14
Georgetown University – Key Competitors 15
Georgetown University – Key Employees 16
Georgetown University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Georgetown University, Pharmaceuticals & Healthcare, Key Facts 2
Georgetown University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Georgetown University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Georgetown University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Georgetown University, Deals By Therapy Area, 2012 to YTD 2018 8
Georgetown University, Medical Devices Deals, 2012 to YTD 2018 9
Georgetown University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Georgetown Lombardi Comprehensive Cancer Center Partners with John Theurer Cancer Center 11
CalAsia Pharma Enters Into Co-Development Agreement With Georgetown University 12
Amarantus BioScience Enters into Option for Licensing Agreement with Georgetown University 13
BioMetrx Enters Into Licensing Agreement With Georgetown University Medical Center For Rasstore 14
Georgetown University, Key Competitors 15
Georgetown University, Key Employees 16
Georgetown University, Subsidiaries 18

List of Figures
Georgetown University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Georgetown University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Georgetown University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Georgetown University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Georgetown University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Georgetown University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Georgetown University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Georgetown University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Georgetown University, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Georgetown University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Revance Therapeutics Inc (RVNC)-医療機器分野:企業M&A・提携分析
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Valeant Pharmaceuticals International, Inc.:企業の戦略・SWOT・財務情報
    Valeant Pharmaceuticals International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Valeant Pharmaceuticals International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • CMP Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CMP Pharma Inc (CMP Pharma), formerly Carolina Medical Products Company Inc is a specialty pharmaceutical company that develops and manufactures generic prescription, non-prescription and skin care products. The company’s prescription products include SPS suspension, isoniazid oral solution …
  • Exar Corporation:企業のM&A・事業提携・投資動向
    Exar Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Exar Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Guided Therapeutics Inc (GTHP):医療機器:M&Aディール及び事業提携情報
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-inv …
  • Gene Biotherapeutics Inc (CRXM):企業の財務・戦略的SWOT分析
    Gene Biotherapeutics Inc (CRXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Minnkota Power Cooperative Inc:企業の発電所・SWOT分析2018
    Minnkota Power Cooperative Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • International Paper Co:企業の戦略・SWOT・財務情報
    International Paper Co - Strategy, SWOT and Corporate Finance Report Summary International Paper Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • K’s Holdings Corporation:企業の戦略・SWOT・財務情報
    K's Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary K's Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Clariant Chemicals (India) Limited (CLNINDIA):企業の財務・戦略的SWOT分析
    Clariant Chemicals (India) Limited (CLNINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Aselsan Elektronik Sanayi Ve Ticaret A.S.:企業の戦略・SWOT・財務情報
    Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Quark Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Quark Pharmaceuticals Inc (Quark), a subsidiary of SBI Biotech Co Ltd, is a clinical-stage pharmaceutical company in the development of novel RNAi-based therapeutics. It offers under development products which include PF-655, a synthetic siRNA which is used for the treatment of diabetic macu …
  • Sanochemia Pharmazeutika AG (SAC)-製薬・医療分野:企業M&A・提携分析
    Summary Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio i …
  • RCM Technologies Inc (RCMT):企業の財務・戦略的SWOT分析
    RCM Technologies Inc (RCMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Scottish Power Ltd:企業の発電所・SWOT分析2018
    Scottish Power Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • First Abu Dhabi Bank (FAB):企業の財務・戦略的SWOT分析
    First Abu Dhabi Bank (FAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • AltaGas Ltd (ALA):電力:M&Aディール及び事業提携情報
    Summary AltaGas Ltd (AltaGas) is an energy utility. The company undertakes activities related to extraction, transmission, distribution and storage of natural gas. AltaGas generates electricity utilizing diverse fuel sources, including wind, run-of-river hydro, geothermal and gas-fired generation pl …
  • Lamar Advertising Company (LAMR):企業の財務・戦略的SWOT分析
    Lamar Advertising Company (LAMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Rakuten, Inc. (4755):企業の財務・戦略的SWOT分析
    Rakuten, Inc. (4755) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • EPI Ingredients:企業の戦略・SWOT・財務情報
    EPI Ingredients - Strategy, SWOT and Corporate Finance Report Summary EPI Ingredients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆